当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 现金流量表

睿智医药

(300149)

  

流通市值:46.65亿  总市值:48.95亿
流通股本:4.75亿   总股本:4.98亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金266,772,898.371,110,410,556.03812,104,041.96533,876,099.3
  收到的税费返还9,940,782.3131,033,017.7629,282,855.4919,989,504.5
  收到其他与经营活动有关的现金6,560,715.8719,893,705.4523,662,504.0229,151,254.93
  经营活动现金流入小计283,274,396.551,161,337,279.24865,049,401.47583,016,858.73
  购买商品、接受劳务支付的现金106,691,183.08327,934,107.22309,756,724.28215,206,485.71
  支付给职工以及为职工支付的现金130,687,297.09525,807,801.35396,424,765.31273,972,450.02
  支付的各项税费2,718,752.8617,391,764.7115,441,909.6710,911,502.02
  支付其他与经营活动有关的现金1,896,299.2499,704,797.6423,190,832.0917,591,336.59
  经营活动现金流出小计241,993,532.27970,838,470.92744,814,231.35517,681,774.34
  经营活动产生的现金流量净额41,280,864.28190,498,808.32120,235,170.1265,335,084.39
二、投资活动产生的现金流量:
  收回投资收到的现金060,000,00030,00030,000
  取得投资收益收到的现金23,186.58252,444.2824,395.5223,695.95
  处置固定资产、无形资产和其他长期资产收回的现金净额8,990179,097.7930,064,162.6430,003,350
  收到的其他与投资活动有关的现金17,683,010.6566,763,414.2749,282,542.9231,555,864.86
  投资活动现金流入小计17,715,187.23127,194,956.3479,401,101.0861,612,910.81
  购建固定资产、无形资产和其他长期资产支付的现金13,775,377.8462,469,661.4541,657,076.1230,068,772.95
  投资支付的现金7,362,499.9721,650,00010,050,00010,050,000
  支付其他与投资活动有关的现金8,528,300112,980,00082,180,00049,700,000
  投资活动现金流出小计29,666,177.81197,099,661.45133,887,076.1289,818,772.95
  投资活动产生的现金流量净额-11,950,990.58-69,904,705.11-54,485,975.04-28,205,862.14
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,823,921.57---
  其中:子公司吸收少数股东投资收到的现金4,823,921.57---
  取得借款收到的现金100,00021,000,0005,000,0001,000,000
  收到其他与筹资活动有关的现金-66,300,00035,300,00035,300,000
  筹资活动现金流入小计4,923,921.5787,300,00040,300,00036,300,000
  偿还债务支付的现金505,152.2147,531,700.1414,260,0004,260,000
  分配股利、利润或偿付利息支付的现金-2,901,138.181,335,912.181,178,828.85
  支付其他与筹资活动有关的现金5,979,594.18116,578,402.9689,756,965.7980,670,392.49
  筹资活动现金流出小计6,484,746.39167,011,241.28105,352,877.9786,109,221.34
  筹资活动产生的现金流量净额-1,560,824.82-79,711,241.28-65,052,877.97-49,809,221.34
四、汇率变动对现金及现金等价物的影响-8,049,152.711,149,651.1-1,754,786.44633,349.4
五、现金及现金等价物净增加额19,719,896.1742,032,513.03-1,058,469.33-12,046,649.69
  加:期初现金及现金等价物余额405,481,384.83363,448,871.8363,448,871.8363,448,871.8
  期末现金及现金等价物余额425,201,281405,481,384.83362,390,402.47351,402,222.11
补充资料:
  净利润-13,553,054.33-25,345,366.23
  资产减值准备-18,634,175.29-14,443,974.16
  固定资产和投资性房地产折旧-48,932,383.98-28,185,850.01
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-48,932,383.98-28,185,850.01
  无形资产摊销-3,112,684.35-1,457,197.75
  长期待摊费用摊销-46,173,014.54-22,678,784.45
  处置固定资产、无形资产和其他长期资产的损失-41,843.85--6,261,722.68
  固定资产报废损失-1,353,358.44-368,870.39
  公允价值变动损失---15,167.73
  财务费用-18,507,912.26-6,333,606.42
  投资损失--12,154,847.66--12,893,493.74
  递延所得税--6,874,717.94--1,642,109.91
  其中:递延所得税资产减少--7,294,942.77--2,345,794.3
    递延所得税负债增加-420,224.83-703,684.39
  存货的减少-5,917,066.66--1,976,714.9
  经营性应收项目的减少--89,398,246.09--44,063,422.47
  经营性应付项目的增加-23,387,041.61--355,188.92
  其他-54,080,567.03-1,892,070.64
  现金的期末余额-405,481,384.83-351,402,222.11
  减:现金的期初余额-363,448,871.8-363,448,871.8
  现金及现金等价物的净增加额-42,032,513.03--12,046,649.69
公告日期2026-04-292026-04-292025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑